These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30840168)

  • 1. Molecular and functional imaging insights into the role of hypoxia in cancer aggression.
    Kakkad S; Krishnamachary B; Jacob D; Pacheco-Torres J; Goggins E; Bharti SK; Penet MF; Bhujwalla ZM
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):51-64. PubMed ID: 30840168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Agents in Targeting Tumor Hypoxia.
    Zeng Y; Ma J; Zhang S; Wu D
    Curr Med Chem; 2016; 23(17):1775-800. PubMed ID: 26997152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.
    Araos J; Sleeman JP; Garvalov BK
    Clin Exp Metastasis; 2018 Oct; 35(7):563-599. PubMed ID: 30171389
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Qian Y; Von Eyben R; Liu Y; Chin FT; Miao Z; Apte S; Carter JN; Binkley MS; Pollom EL; Harris JP; Prionas ND; Kissel M; Simmons A; Diehn M; Shultz DB; Brown JM; Maxim PG; Koong AC; Graves EE; Loo BW
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1183-1192. PubMed ID: 29859786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Imaging of Hypoxia: PET and MRI.
    Perez RC; Kim D; Maxwell AWP; Camacho JC
    Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1.
    Doktorova H; Hrabeta J; Khalil MA; Eckschlager T
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):166-77. PubMed ID: 26001024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of Tumor Characteristics and Molecular Pathways With PET: Developments Over the Last Decade Toward Personalized Cancer Therapy.
    Marcu LG; Moghaddasi L; Bezak E
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1165-1182. PubMed ID: 29907486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and Metabolism in Metastasis.
    Zhang T; Suo C; Zheng C; Zhang H
    Adv Exp Med Biol; 2019; 1136():87-95. PubMed ID: 31201718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Oxygenation Status: Facts and Fallacies.
    Vaupel P; Mayer A
    Adv Exp Med Biol; 2017; 977():91-99. PubMed ID: 28685432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of a method of high-contrasted nuclear medical imaging of hypoxia-inducible factor-1-active tumor by using a pretargeting approach].
    Ueda M
    Yakugaku Zasshi; 2012; 132(5):595-600. PubMed ID: 22687695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.
    Bache M; Kappler M; Said HM; Staab A; Vordermark D
    Curr Med Chem; 2008; 15(4):322-38. PubMed ID: 18288988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.
    Tatum JL; Kelloff GJ; Gillies RJ; Arbeit JM; Brown JM; Chao KS; Chapman JD; Eckelman WC; Fyles AW; Giaccia AJ; Hill RP; Koch CJ; Krishna MC; Krohn KA; Lewis JS; Mason RP; Melillo G; Padhani AR; Powis G; Rajendran JG; Reba R; Robinson SP; Semenza GL; Swartz HM; Vaupel P; Yang D; Croft B; Hoffman J; Liu G; Stone H; Sullivan D
    Int J Radiat Biol; 2006 Oct; 82(10):699-757. PubMed ID: 17118889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia as a Biomarker and for Personalized Radiation Oncology.
    Vordermark D; Horsman MR
    Recent Results Cancer Res; 2016; 198():123-42. PubMed ID: 27318684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging hypoxia and angiogenesis in tumors.
    Rajendran JG; Krohn KA
    Radiol Clin North Am; 2005 Jan; 43(1):169-87. PubMed ID: 15693655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for Tumor Hypoxia Imaging Based on Aggregation-Induced Emission Fluorogens.
    Xue T; Shen J; Shao K; Wang W; Wu B; He Y
    Chemistry; 2020 Feb; 26(12):2521-2528. PubMed ID: 31692097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging of intratumoral hypoxia.
    Foo SS; Abbott DF; Lawrentschuk N; Scott AM
    Mol Imaging Biol; 2004; 6(5):291-305. PubMed ID: 15380739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric High-Resolution MRI as a Tool for Mapping of Hypoxic Level in Tumors.
    Serša I; Bajd F; Savarin M; Jesenko T; Čemažar M; Serša G
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818797066. PubMed ID: 30176769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIFs, angiogenesis, and cancer.
    Yang Y; Sun M; Wang L; Jiao B
    J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.